Biomimetic Metal-Organic Frameworks as Targeted Vehicles to Enhance Osteogenesis

Although engineered nanoparticles loaded with specific growth factors are used to regulate differentiation of stem cells, the low loading efficiency and biocompatibility are still great challenges in tissue repair. A nature-inspired biomimetic delivery system with targeted functions is attractive for enhancing cell activity and controlling cell fate. Herein, a stem cell membrane (SCM)-wrapped dexamethasone (DEX)-loaded zeolitic imidazolate framework-8 (ZIF-8) is constructed, which integrates the synthetic nanomaterials with native plasma membrane, to achieve efficient DEX delivery and DEX-mediated bone repair. The DEX@ZIF-8-SCM enables high DEX loading capacity, modulates the sustained release, and facilitates the specific uptake of mesenchymal stem cells (MSCs), owing to the porous property of ZIF-8 and the innate targeting capability of SCM. The endocytosed DEX@ZIF-8-SCM shows high cytocompatibility and greatly enhances the osteogenic differentiation of MSCs. Furthermore, RNA-sequencing data reveal that the phosphoinositide 3-kinase (PI3K)-Akt signaling pathways are activated and dominantly involved in the accelerated osteogenesis. In the bone defect model, the administrated DEX@ZIF-8-SCM exerts excellent biocompatibility and effectively promotes bone regeneration. Overall, the SCM-derived biomimetic nanoplatform achieves targeted delivery, excellent biosafety, and enhanced osteogenic differentiation and bone repair, which provides a new and valid strategy for treating various tissue injuries.

Automated summary

In this study, a biomimetic nanoplatform was developed using stem cell membrane-wrapped dexamethasone-loaded zeolitic imidazolate framework-8. The nanoplatform achieved efficient drug delivery and enhanced bone repair through its high loading capacity, sustained release, and specific uptake by mesenchymal stem cells. The nanoplatform showed high cytocompatibility, greatly enhanced osteogenic differentiation, and activated the PI3K-Akt signaling pathways involved in accelerated osteogenesis. In a bone defect model, the nanoplatform exhibited excellent biocompatibility and effectively promoted bone regeneration. This research provides a new and valid strategy for treating tissue injuries.